The LigaSure Curved, Small Jaw, Open Sealer/Divider instrument will be sold in the U.S. starting this quarter.
According to Covidien’s website, LigaSure technology can fuse vessels, including pulmonary vasculature, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds.
Read the Boulder County Business Report on LigaSure.
Read more on device approval:
–FDA Approves EndoSerter Device for Corneal Transplants
–Weight Loss Centers Expect More Business Following FDA Lap-Band Decision
–Anesthesiology Devices Recalled After Weak Oversight by FDA
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
